Temasek, CVC seek buyers for generics firm Alvogen’s eastern European ops

Temasek
FILE PHOTO - A Temasek logo is seen at the annual Temasek Review in Singapore July 7, 2016. REUTERS/Edgar Su

Generics firm Alvogen is putting its Central and Eastern European (CEE) operations up for sale as its private equity owners seek a step-by-step exit from the maker of drugs against cancer, heart and lung diseases, people close to the matter said.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.